Government mandating of prices
For example, if a city is now required to build 100 RHNA units, the new number will be 125 units.More housing means more overcrowded schools, more traffic, fewer parking spaces, and less open space.Under a state program called the Regional Housing Needs Allocation (RHNA), cities are told how many RHNA units to build.SB 828 is requiring the RHNA numbers in cities go up by 25 percent.The problem here is that someone in Sacramento will see this and try to do the same—or maybe a County, like Santa Clara or Marin will do this.“Vancouver, Canada, where real estate prices have been escalating sharply, has sought to temper housing demand by imposing a 15 percent on sales to foreign homes buyers.
The website, , provides information on housing prices in Silicon Valley.
I am not one for raising taxes or using taxes to achieve government goals.
But, I thought you would be interested in how the Socialists in Canada keep prices high—and make foreigners pay more for a home.
Moreover, “[t]hird-party payment” is “a dominant feature of health care markets,” distinguishing them from the markets for other consumer goods. The impact of pharmaceutical prices and rates of utilization on the cost of the Medicare and Medicaid programs, and the Secretary’s mandate to minimize unreasonable program expenditures, provided the “nexus” between the Secretary’s responsibilities and the proposed regulation. Nevertheless, the cost of drugs and biologics to the federal government, Medicare beneficiaries, and State Medicaid programs had increased “at an alarming rate,” and in the Secretary’s view “DTC advertising without price transparency has a direct nexus to these trends of increasing price and utilization” ( the increased use of pharmaceuticals). In CMS’s view, “[p]rice transparency will help improve the efficiency of Medicare and Medicaid programs by reducing wasteful and abusive increases in drug and biological list prices.” It will incentivize manufacturers to reduce their list prices and provide consumers with information to help them play an “active and well informed” role “in their health care decision-making.” Id. The .2 billion pharmaceutical companies spent on television advertising in 2017 appeared to CMS to affect drug utilization; “consumers exposed to drug advertisements can exert sufficient pressure on their physicians to prescribe the advertised product.” Id. The mandated disclosure requirements applied to all advertisements on television, which the CMS defined to include broadcast, cable, streaming, and satellite transmission.
CMS explained that consumers cannot easily ascertain drugs’ and biologics’ actual or list prices. CMS noted that Congress had recognized the value of drug price transparency in two provisions of the Social Security Act, but acknowledged that Congress had not “explicitly provided HHS with authority to compel the disclosure of list prices to the public.” Id. CMS had tentatively concluded that application of the requirement to other communications media was unwarranted, but sought comment on that issue.